Stephen D. Baird

Ottawa, ON K1H8L1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Hexosamine Pathway Disruption by GFPT1 Loss Drives Coordinated Defects in Glycosylation, Autophagy, and Trafficking.

Hexosamine Pathway Disruption by GFPT1 Loss Drives Coordinated Defects in Glycosylation, Autophagy, and Trafficking.

Journal: Biomolecules

Published: May 01, 2026

Smaller scale, same impact: replicating high-throughput phenotypic profiling in a medium-throughput lab for use in chemical risk assessment.

Smaller scale, same impact: replicating high-throughput phenotypic profiling in a medium-throughput lab for use in chemical risk assessment.

Journal: Archives of toxicology

Published: June 10, 2025

SIFD-associated TRNT1 deficiency unveils importance of TSPO during macrophage antibacterial and antiviral responses.

SIFD-associated TRNT1 deficiency unveils importance of TSPO during macrophage antibacterial and antiviral responses.

Journal: Frontiers in immunology

Published: September 17, 2024

Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis.

Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis.

Journal: Cellular and molecular life sciences : CMLS

Published: May 20, 2023

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

Journal: International journal of molecular sciences

Published: December 15, 2022

Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43.

Engineered autophagy receptors administered with extracellular vesicles eliminate pathological Tau and TDP-43.

Journal: Nature biomedical engineering

Published: November 19, 2021

High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1).

High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1).

Journal: PloS one

Published: October 02, 2020

Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK.

Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK.

Journal: Oncogene

Published: June 22, 2020

The transcription factor SP3 drives TNF-α expression in response to Smac mimetics.

The transcription factor SP3 drives TNF-α expression in response to Smac mimetics.

Journal: Science signaling

Published: January 31, 2019

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.

Journal: Journal of visualized experiments : JoVE

Published: April 24, 2018

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy.

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy.

Journal: Neurology. Genetics

Published: March 23, 2018

The Keap1-Nrf2 Stress Response Pathway Promotes Mitochondrial Hyperfusion Through Degradation of the Mitochondrial Fission Protein Drp1.

The Keap1-Nrf2 Stress Response Pathway Promotes Mitochondrial Hyperfusion Through Degradation of the Mitochondrial Fission Protein Drp1.

Journal: Antioxidants & redox signaling

Published: May 13, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026